AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
PMV Pharmaceuticals, Inc
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG007NM4862
1.27▼ 0.03 (-2.68%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
—
Net Debt
Trading Information
Previous Close
1.31
Day's Range
1.26 – 1.33
52-Week Range
1.02 – 1.91
Volume
171.0K
Avg Volume
760.6K
Share Statistics
Shares Outstanding
Employees
54
Exchange
XNAS
Listed
2020-09-25
Share count as of August 14, 2026

PMV Pharmaceuticals, Inc (PMVP) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about PMV Pharmaceuticals, Inc (PMVP)
What is PMV Pharmaceuticals, Inc's Market Cap?
PMV Pharmaceuticals, Inc's Market Cap is $67.9M, based on as-reported figures from SEC (XBRL) filings.
What is PMV Pharmaceuticals, Inc's Enterprise Value?
PMV Pharmaceuticals, Inc's Enterprise Value is -$11.5M, based on as-reported figures from SEC (XBRL) filings.
What is PMV Pharmaceuticals, Inc's EV / EBITDA?
PMV Pharmaceuticals, Inc's EV / EBITDA is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is PMV Pharmaceuticals, Inc's Net Income (TTM)?
PMV Pharmaceuticals, Inc's Net Income (TTM) is -$75.2M, based on as-reported figures from SEC (XBRL) filings.
What is PMV Pharmaceuticals, Inc's EBITDA?
PMV Pharmaceuticals, Inc's EBITDA is -$79.5M, based on as-reported figures from SEC (XBRL) filings.
What is PMV Pharmaceuticals, Inc's Diluted EPS (TTM)?
PMV Pharmaceuticals, Inc's Diluted EPS (TTM) is -1.41, based on as-reported figures from SEC (XBRL) filings.
What is PMV Pharmaceuticals, Inc's Net Debt?
PMV Pharmaceuticals, Inc's Net Debt is -$79.4M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · PMVPAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Operating expenses:
Total research and development
Total general and administrative
Total operating expenses
Loss from operations
Other income (expense):
Interest income, net
Other income (expense), net
Total other income
Loss before (benefit) for income taxes
Provision (benefit) for income taxes
Net loss
Net loss per share - basic
Net loss per share - diluted